Ivermectin confers benefits in the treatment of COVID-19 – Research
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement. The study included 280 patients (mean age, 59.6 years; 45.4 percent female), 173 of whom received ivermectin and 107 did not. Most patients in both groups
Recent Comments